Bridgefront Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,782
Closed -$299K 676
2025
Q4
$299K Buy
+3,782
New +$299K 0.08% 374
2025
Q3
Sell
-10,413
Closed -$837K 724
2025
Q2
$837K Buy
10,413
+7,542
+263% +$582K 0.22% 140
2025
Q1
$231K Buy
+2,871
New +$239K 0.07% 470
2024
Q4
Sell
-3,515
Closed -$290K 703
2024
Q3
$290K Buy
+3,515
New +$263K 0.11% 328
2024
Q1
Sell
-4,484
Closed -$297K 490
2023
Q4
$297K Buy
+4,484
New +$281K 0.22% 174
2023
Q3
Sell
-7,456
Closed -$421K 527
2023
Q2
$421K Buy
+7,456
New +$414K 0.23% 162
2022
Q2
Sell
-3,854
Closed -$271K 390
2022
Q1
$271K Sell
3,854
-947
-20% -$64K 0.33% 130
2021
Q4
$300K Buy
+4,801
New +$301K 0.29% 144
2021
Q3
Sell
-8,748
Closed -$524K 549
2021
Q2
$524K Buy
+8,748
New +$554K 0.2% 163

Other funds holding MET

Bridgefront Capital's MET Position: Q1 2026 in Review

Bridgefront Capital sold out of MetLife (MET) in Q1 2026, closing a stake of 3,782 shares — an estimated $299K sold.

Bridgefront Capital first reported a position in MET in Q2 2021 and held it in 9 quarters. The position peaked at $837K in Q2 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Bridgefront Capital reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 3,782 MetLife shares in Q1 2026, an estimated $299K.
  • Bridgefront Capital first reported a position in MetLife in Q2 2021 and held it in 9 quarters.
  • Bridgefront Capital's MetLife position peaked at $837K in Q2 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.